TPO IGG ELISA.
ESTÁ DISEÑADO PARA LA DETECCIÓN CUALITATIVA Y SEMI-CUANTITATIVA DE ANTICUERPOS DE CLASE IGG CONTRA LA PEROXIDASA TIROIDEA (TPO) EN SUERO HUMANO. EL SISTEMA DE PRUEBA ESTÁ DESTINADO PARA SER UTILIZADO COMO AYUDA EN EL DIAGNÓSTICO DE ENFERMEDADES TIROIDEAS.
IT IS DESIGNED FOR THE QUALITATIVE AND SEMI-QUANTITATIVE DETECTION OF IGG CLASS ANTIBODIES AGAINST THYROID PEROXIDASE (TPO) IN HUMAN SERUM. THE TEST SYSTEM IS INTENDED TO BE USED AS AN AID IN THE DIAGNOSIS OF THYROID DISEASES.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA DETECTAR ANTICUERPOS DE CLASE IGG CONTRA PEROXIDASA TIROIDEA (TPO).
- Trade Name (English)
- REAGENT TO DETECT IGG ANTIBODIES AGAINST THYROID PEROXIDASE (TPO).
- Analysis ID
- 2078R2019 SSA
- Registration Date
- November 05, 2019
- Name (Spanish)
- DIAGMEX, S.A. DE C.V.
- Name (English)
- DIAGMEX, S.A. DE C.V.
Access comprehensive regulatory information for TPO IGG ELISA. (TPO IGG ELISA.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2078R2019 SSA and manufactured by DIAGMEX, S.A. DE C.V.. The device was registered on November 05, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.